Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Medicareplus International is a UK healthcare products company focused on skin protection and wound management rather than therapeutics development. The company manufactures and distributes evidence-based products for wound care, continence care, and stoma care, with flagship ranges including Medi Derma-S, Medi Derma-PRO, and AbsoPad. Its commercial strategy is built around the Total Barrier Protection framework and the S.M.A.R.T. tool for prevention and management of moisture-associated skin damage. Medicareplus works with NHS and private-sector customers, and also provides clinical education and training programs for healthcare professionals. The business appears to be an active private company operating commercially in the UK and expanding internationally through distributor partnerships.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Medicareplus International.